Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Weiner

Showing results (191-200 of 1,343) with videos related to

Pageof 135
Sort By:
Progress in Brain Research|January 1, 1983
Immunoregulation in multiple sclerosisH L Weiner, S L Hauser
Nature Biotechnology|May 7, 2016
Inducing tolerance one antigen at a timeRafael M Rezende, Howard L Weiner
Annals of Neurology|March 1, 1988
Immunotherapy of multiple sclerosisH L Weiner, D A Hafler
Seminars in Dialysis|February 24, 2017
Venous Hemodialysis Catheters and Cardiac Implantable Electronic Devices: Avoiding a High-Risk CombinationTheodore F Saad, Henry L Weiner
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 22, 2021
Correspondence concerning "Cerebellitis as a neurosurgical disease in pediatrics" by Goethe EA, LoPresti M, Bertot B, Lam S. J Clinical Neurosci (2021;85:57-63)Thierry A Huisman, Howard L Weiner
Neurobiology of Stress|December 18, 2024
Withdrawal notice to: "Elevated GABAergic neurotransmission prevents chronic intermittent ethanol induced hyperexcitability of intrinsic and extrinsic inputs to the ventral subiculum of female rats" [Neurobiol. Stress 32 (2024) 100665]Eva C Bach, Jeff L Weiner
Immunology Letters|April 8, 2022
Oral tolerance: an updated reviewRafael M Rezende, Howard L Weiner
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1986
Antigen presentation by astrocytes--a commentaryL A Levin, H L Weiner
International Review of Neurobiology|March 2, 2021
The neural, behavioral, and epidemiological underpinnings of comorbid alcohol use disorder and post-traumatic stress disorderHannah N Carlson, Jeff L Weiner
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 18, 2005
Monitoring participant safety in phase I and II interventional trials: options and controversiesPatricia L Hibberd, Debra L Weiner
Pageof 135

Showing results (191-200 of 1,343) with videos related to

Sort By:
Pageof 135
Progress in Brain Research|January 1, 1983
Immunoregulation in multiple sclerosisH L Weiner, S L Hauser
Nature Biotechnology|May 7, 2016
Inducing tolerance one antigen at a timeRafael M Rezende, Howard L Weiner
Annals of Neurology|March 1, 1988
Immunotherapy of multiple sclerosisH L Weiner, D A Hafler
Seminars in Dialysis|February 24, 2017
Venous Hemodialysis Catheters and Cardiac Implantable Electronic Devices: Avoiding a High-Risk CombinationTheodore F Saad, Henry L Weiner
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 22, 2021
Correspondence concerning "Cerebellitis as a neurosurgical disease in pediatrics" by Goethe EA, LoPresti M, Bertot B, Lam S. J Clinical Neurosci (2021;85:57-63)Thierry A Huisman, Howard L Weiner
Neurobiology of Stress|December 18, 2024
Withdrawal notice to: "Elevated GABAergic neurotransmission prevents chronic intermittent ethanol induced hyperexcitability of intrinsic and extrinsic inputs to the ventral subiculum of female rats" [Neurobiol. Stress 32 (2024) 100665]Eva C Bach, Jeff L Weiner
Immunology Letters|April 8, 2022
Oral tolerance: an updated reviewRafael M Rezende, Howard L Weiner
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1986
Antigen presentation by astrocytes--a commentaryL A Levin, H L Weiner
International Review of Neurobiology|March 2, 2021
The neural, behavioral, and epidemiological underpinnings of comorbid alcohol use disorder and post-traumatic stress disorderHannah N Carlson, Jeff L Weiner
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 18, 2005
Monitoring participant safety in phase I and II interventional trials: options and controversiesPatricia L Hibberd, Debra L Weiner
Pageof 135